Hetrombopag has demonstrated strong efficacy and a favourable safety profile in children with immune thrombocytopenia, according to newly published clinical findings. The data support the use of the thrombopoietin receptor agonist as an effective second-line treatment option in paediatric patients who do not respond adequately to first-line therapy. Immune thrombocytopenia…
Tag: #PaediatricCare
News
How Winter Shapes Children’s Growth & Immunity
Winter brings festive cheer, holidays, and cosy moments for families, but medical experts warn that the cold season can quietly challenge children’s health. Paediatricians say winter often weakens children’s immunity and can subtly affect physical growth, especially in younger age groups whose bodies are still developing. Parents commonly notice a…